Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

(2012) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs

(2012) Saroj Niraula et al.   JOURNAL OF CLINICAL ONCOLOGY

Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer

(2012) H. K. Gan et al.   JNCI-Journal of the National Cancer Institute

Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review

(2012) J. Peron et al.   JNCI-Journal of the National Cancer Institute

Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review

(2012) Shannon M. Smith et al.   PAIN

An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials

(2011) Lucy-Ann Turner et al.   BMC Complementary and Alternative Medicine

Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms

(2011) Arif A. Shukralla et al.   EPILEPSY RESEARCH

Quality of Randomized Controlled Trials Reporting in the Treatment of Sarcomas

(2011) Maud Toulmonde et al.   JOURNAL OF CLINICAL ONCOLOGY

Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review

(2011) Benoit You et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety profile of new anticancer drugs

(2010) Laura Mansi et al.   Expert Opinion On Drug Safety

The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals

(2010) Anna-Bettina Haidich et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature

(2010) Rodney H. Breau et al.   JOURNAL OF UROLOGY

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

(2009)   ARCHIVES OF INTERNAL MEDICINE

Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review

(2009) M. Y. Chowers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention

(2009) Morgane Ethgen et al.   Trials

Abstracts in high profile journals often fail to report harm

(2008) Enrique Bernal-Delgado et al.   BMC Medical Research Methodology

Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature

(2008) Lorena P. Rios et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM